Evidence map›Paper›PMID 28081744›Full record

ArticleOncology research2017

ERRATUM.

Min Zhao, Zhiying Su, Shiyang Zhang, Liangjin Zhuang, Yudi Xie, Xiaodong Li

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Oncology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Min ZhaoDepartment of Gynaecology and Obstetrics, The First Affiliated Hospital of Xiamen UniversityXiamen, FujianChina.
Zhiying SuDepartment of Obstetrics, Maternal and Child Health Hospital of Xiamen CityXiamen, FujianChina.
Shiyang ZhangDepartment of Hospital Infection-Control, The First Affiliated Hospital of Xiamen UniversityXiamen, FujianChina.
Liangjin ZhuangEarly cancer screening center, The First Affiliated Hospital of Xiamen UniversityXiamen, FujianChina.
Yudi XieDepartment of Gynaecology and Obstetrics, The First Affiliated Hospital of Xiamen UniversityXiamen, FujianChina.
Xiaodong LiDepartment of Gynaecology and Obstetrics, The First Affiliated Hospital of Xiamen UniversityXiamen, FujianChina.
First Affiliated Hospital of Xiamen University · CNXiamen Maternal and Child Health Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer (OC) is one of the most common gynecological malignancies. MicroRNAs (miRs) play a crucial role in the development and progression of OC, but the underlying mechanism remains largely unclear. Our study investigated the regulatory role of miR-148a in OC cell proliferation and invasion. We found that miR-148a was significantly downregulated in OC tissues compared to their matched adjacent nontumor tissues. In addition, its expression was also reduced in OC cell lines (SKOV3, ES-2, OVCAR, and A2780) compared to normal ovarian epithelial cells. Overexpression of miR-148a caused a significant decrease in OC cell proliferation and invasion, as well as reduced MMP9 protein levels. Transforming growth factor-β-induced 2 (TGFI2) was further identified as a target gene of miR-148a, and its protein expression was downregulated in OC cells after miR-148a overexpression. Restoration of TGFI2 attenuated the suppressive effects of miR-148a on OC cell proliferation and invasion. Moreover, we found that TGFI2 was remarkably upregulated in OC tissues when compared with their matched adjacent nontumor tissues, and observed a reverse correlation between miR-148a and TGFI2 expression in OC tissues. On the basis of these findings, we suggest that miR-148a inhibits OC cell proliferation and invasion partly through inhibition of TGFI2. Therefore, our study highlights the importance of the miR-148a/TGFI2 axis in the malignant progression of OC.

Identifiers

PMID28081744
PMCPMC7840779
OpenAlexW4233766292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.